Seroxine XR

Quick links

Choose a section

Quick links to important sections

Advertisements

Seroxine XR

Advertisements

Overview of Seroxine XR

Property Description
Active ingredient Venlafaxine (as hydrochloride salt)
Form Extended-release capsule
Pharmacological class Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Common use Mood and emotional stabilization
Origin Synthetic compound

Seroxine XR is a prescription-only medication classified as a dual-acting antidepressant whose foundation is the synthetic compound Venlafaxine. This psychotropic agent belongs to the pharmacological class known as Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs).

What Type of Medicine is Seroxine XR?

Seroxine XR is an SNRI because its function is to block the reabsorption (reuptake) of the two key neurotransmitters, Serotonin and Norepinephrine, in the brain's Central Nervous System (CNS). This activity causes the concentrations of these chemical messengers to increase within the synapses, a process known as potentiation of neurotransmitter activity. Venlafaxine is clinically recognized for its affinity to these two specific reuptake pumps, a mechanism that supports its use in addressing neurochemical imbalances. Venlafaxine is chemically distinct from single-action compounds, and its structure is classified as a bicyclic ethyl-cyclohexanol derivative.

How is Seroxine XR Formulated?

The medication is formulated as an extended-release capsule, a solid dosage form intended for oral administration. The ‘XR’ specifically refers to a modified-release delivery system, which is the distinguishing feature of the product. This system is engineered to release the active ingredient Venlafaxine hydrochloride slowly and consistently into the bloodstream over approximately 24 hours. The purpose of this extended-release formulation is to maintain stable drug levels, which can lead to reduced fluctuations in concentration compared to immediate-release forms. This once-daily delivery method is a key factor in how the drug is typically used to support sustained emotional stability.

What is the General Purpose of Seroxine XR?

The general purpose of Seroxine XR is to help stabilize mood and emotional state by assisting in the restoration of neurochemical balance. The dual-acting mechanism helps achieve this by modulating both serotonergic and noradrenergic systems simultaneously. Ultimately, this potentiation of neurotransmitter activity is employed to alleviate symptoms associated with mood dysregulation, offering therapeutic support for individuals experiencing significant emotional distress.

Advertisements

What side effects are possible with Seroxine XR?

Possible Side Effects and Safety Information

The safety profile of Seroxine XR (Venlafaxine) is structured by regulatory authorities based on the incidence and nature of reported adverse reactions. These reactions are grouped into categories such as Very Common (occurring in 1 in 10 patients or more) and Common (occurring in 1 in 100 to less than 1 in 10 patients) within clinical trial data. Effects most frequently documented include nausea, dry mouth, headache, somnolence (drowsiness), insomnia, and increased sweating.


System-Organ Classification and Clinically Significant Reactions

The officially listed adverse effects span several System-Organ Classes, including Gastrointestinal, Nervous System, Psychiatric, and Vascular Disorders. Serious adverse reactions are documented, requiring particular attention. These include the risk of Serotonin Syndrome, significant or sustained Hypertension (increased blood pressure), the potential for Angle-closure Glaucoma, and the documented risk of seizures.


Population-Specific Safety Considerations and Restrictions

The regulatory label carries specific safety considerations for certain patient groups. For example, the medication is not approved for pediatric use due to an elevated risk of suicidal thoughts and behaviors in that age group. Patients with renal or hepatic impairment typically require a reduction in the total daily dose due to altered drug clearance. Furthermore, the label requires regular blood pressure monitoring due to the drug's known potential to cause dose-related increases in blood pressure, and it is contraindicated for concurrent use with Monoamine Oxidase Inhibitors (MAOIs). Adverse reactions are often more common at the start of treatment or during dose escalation.

Advertisements

Overdose and Emergency Response

Overdose Manifestations and Complications

Overexposure to Seroxine XR (Venlafaxine) is officially documented in regulatory information with a characteristic profile of severe central nervous system (CNS) and cardiovascular manifestations. Documented CNS symptoms can include drowsiness, agitation, dizziness, and seizures, potentially leading to coma in severe cases. Cardiovascular effects described in official labeling include tachycardia (rapid heartbeat) and fluctuations in blood pressure, ranging from hypertension to hypotension.

Regulatory authorities cite specific high-risk systemic outcomes. These include the potentially life-threatening reaction known as Serotonin Syndrome and signs of cardiac toxicity, which may involve ventricular dysrhythmias or specific ECG abnormalities such as QRS widening. The risk of serious complications is noted to be increased in cases of mixed overdose, and prolonged observation is required due to the nature of the extended-release formulation.

Mandated Emergency Action

Due to the severity of documented outcomes, regulatory documents provide clear mandates for emergency action. Immediate medical attention must be sought for any suspected overdosage. Management is defined as strictly symptomatic and supportive, as no specific antidote is known for Venlafaxine. Officially described management procedures require initiation of continuous cardiac monitoring and maintenance of vital functions, with some guidelines noting the need for specific interventions, such as the use of activated charcoal, based on clinical context.

Advertisements

Therapeutic Uses of Seroxine XR

What Seroxine XR Treats: Main Uses and Benefits

Seroxine XR is an extended-release medication commonly used to help with conditions characterized by periods of heightened symptoms in adult patients. It is applied across therapeutic domains where additional symptomatic support is needed, addressing groups of symptoms that may appear suddenly or intensify over time. This approach is relevant for easing symptoms associated with Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Social Anxiety Disorder.

The medication supports general well-being during symptomatic phases and assists with maintaining functional stability, and is relevant for managing symptoms that may intensify temporarily or recur. It is commonly used in scenarios where symptoms create noticeable functional strain. It contributes to easing the overall symptom load by managing pervasive worry and the acute physical manifestations of distress, supporting patients during difficult episodes.

The therapeutic benefit is associated with symptomatic relief across key domains, helping patients cope more steadily with symptom fluctuations and assists with maintaining functional stability in routine activities.


Quick Fact: Relief for Pathological Worry

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Scope

Seroxine XR's use is strictly defined by regulatory documents and is approved for use in adults aged 18 years and older. Use is not indicated for pediatric patients under 18 years of age.


Absolute Contraindications

The medicine is contraindicated and must not be used in patients with a known hypersensitivity to venlafaxine or any component of the formulation. It is also strictly prohibited for patients concurrently taking a Monoamine Oxidase Inhibitor (MAOI) intended to treat psychiatric disorders. The official label mandates a specific washout period: the medicine is contraindicated within 14 days of stopping a psychiatric MAOI, or if an MAOI is to be started within 7 days of stopping Seroxine XR.


Restricted and Conditional Use

Eligibility is conditional for patients with renal impairment or hepatic impairment, requiring mandatory dose adjustments based on the severity of the organ dysfunction, as outlined in regulatory labeling. Caution is also advised for older individuals. Use in pregnant or breastfeeding individuals is restricted; while the drug is excreted into human milk, use is permitted only if the potential benefit clearly justifies the potential risk. Additional restrictions apply to patients with uncontrolled hypertension, a history of seizures, or a risk for angle-closure glaucoma.

Advertisements

What should I know about interactions with other medicines?

Seroxine XR Interactions with other medicines and products

Seroxine XR, as a serotonergic agent, is associated with two primary types of drug-drug interactions: pharmacodynamic and pharmacokinetic.

Pharmacodynamic Interactions

Concomitant use with other serotonergic agents is officially documented to increase the risk of Serotonin Syndrome, a potentially life-threatening condition resulting from excessive serotonin activity in the central nervous system. This class of interacting products includes Monoamine Oxidase Inhibitors (MAOIs)—a combination that is contraindicated. A washout period of a specified number of days must be observed when switching between Seroxine XR and an MAOI. Other high-risk combinations include Triptans, Fentanyl, Tramadol, and other antidepressants like SNRIs.

Pharmacokinetic Interactions

Seroxine XR and its metabolites may inhibit certain Cytochrome P450 (CYP) enzymes, notably CYP2D6. Co-administration with drugs primarily metabolized by CYP2D6 can lead to higher systemic exposure of the co-administered drug, potentially requiring a dose adjustment. This is particularly relevant for drugs with a narrow therapeutic index, such as certain antiarrhythmics or antipsychotics. Additionally, concurrent use with non-steroidal anti-inflammatory drugs (NSAIDs), aspirin, or other anticoagulants may elevate the risk of clinically significant bleeding events.

Advertisements

Mechanism of Action

The pharmacological activity of Seroxine XR is defined by its poly-pharmacological mechanism in the central nervous system. The primary mechanism involves antagonism (blockade) at the Serotonin 5- HT2A and Dopamine D2 receptors. D2 antagonism is characterized by rapid dissociation, allowing for dynamic receptor activity. The active metabolite, norquetiapine, provides synergistic action by functioning as a partial agonist at 5- HT1A receptors and an inhibitor of the Norepinephrine Transporter (NET). This dual modulation of serotonin and dopamine pathways, amplified by increased norepinephrine concentration, results in the modulation of neural signaling patterns in targeted brain circuits. The drug also acts as a potent antagonist at Histamine H1 and Adrenergic alpha1 receptors. H1 blockade influences pathways controlling alertness, leading to a reduction in central H1 receptor-mediated activity. alpha1 antagonism affects the sympathetic nervous system, resulting in altered vascular tone and positional blood pressure changes.

Advertisements

Dosage and Administration Information

How to use Seroxine XR

The administration of Seroxine XR is structured to ensure the extended-release properties of the capsule are maintained. The medication is an oral formulation used under a once-daily (OD) dosing schedule.

Feature Official Instruction
Route of administration: Oral route only.
Dosing schedule: Standard adult use is often initiated at 75 mg/day. Doses are increased in increments up to 75 mg/day at intervals of not less than four days. The general maximum daily dose generally does not exceed 225 mg/day.
Timing in relation to meals: Must be taken with food at approximately the same time each day.
Preparation requirements: The capsule must be swallowed whole with fluid and should not be crushed, chewed, or divided. Contents may be carefully dispersed on a small amount of applesauce and swallowed immediately.
Population-specific adjustments: Dose reduction is specified for patients with impaired function, such as a reduction of 25% to 50% for renal impairment and a 50% reduction for mild to moderate hepatic impairment.
Special procedural conditions: Treatment discontinuation requires a gradual dose reduction (tapering) process.

Connection to the Official Use Protocol

These instructions establish a structured protocol centered on once-daily, oral administration to ensure the integrity of the extended-release mechanism. This regimen is defined by specific starting, maintenance, and maximum doses, along with mandated tapering to guide the structural initiation, adjustment, and conclusion of the use protocol.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase III Clinical Trial Findings

Research investigated the effect on the frequency and severity of migraine attacks.

One Phase III, double-blind, placebo-controlled trial, published in 2023, evaluated outcomes related to a reduction in the average number of monthly migraine days. The primary endpoint examined the change in the mean number of migraine days from baseline over a three-month period.

In the study, participants commenced treatment at the lowest dose, with the option for dose adjustment based on prespecified criteria. The research explored whether there was an association with a reduction in the use of acute medications during the trial period. The studies examined measured outcomes for episodic and chronic migraine.


Patient-Reported Outcomes and Tolerability

Data on safety and tolerability were collected and reported across all studies. Side effects explored included nausea, dizziness, and injection site reactions (for the injectable formulation). Adverse events reported were often categorized as mild to moderate in severity.

Some study participants reported a perception of subjective change, though formal onset-of-action data varied across the research. Participants who experienced treatment-related adverse events were instructed to contact the research team immediately.


Combination Therapy Studies

Research investigated whether the combination was associated with patient compliance and sustained response. Studies compared outcomes of the dual mechanism with monotherapy options, examining potential differences in measured endpoints.


Long-Term Safety Profile

Long-term extension studies tracked the safety profile of the treatment over extended periods, monitoring potential shifts in side effect profiles and measured outcomes over time. Research explored whether the drug was associated with changes in the duration and frequency of headaches over the extended study phase. In the studies, participants were advised against concomitant use with alcohol.

Key Studies & References

  1. A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of [Seroxine XR Active Ingredient] Injections for the Prevention of Episodic Migraine (MINT-E)
  2. A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of [Seroxine XR Active Ingredient] Injections for the Prevention of Chronic Migraine (MINT-C)
  3. Open-label Extension Study Evaluating the Long-term Safety and Efficacy of [Seroxine XR Active Ingredient] Orally Inhaled for the Treatment of Pulmonary Arterial Hypertension (PROSERA-EXT)
  4. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (AHRQ)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Seroxine XR (FAQ)


Q: What is the main difference between Seroxine XR and the regular Seroxine pill?

A: The key difference is the speed at which the medicine is released into the body. The XR (extended-release) formulation is engineered to release the active ingredient slowly over a 24-hour period, which supports its once-daily dosing schedule. Official documents describe this formulation as having a slower rate of absorption compared to the immediate-release tablet, while ensuring the same amount of medicine is absorbed overall.


Q: What should I do if I forget to take a dose of Seroxine XR?

A: The official patient information provides guidance if a dose is missed. The instruction is to take the dose as soon as it is remembered. However, if it is closer to the time of the next scheduled dose, the official instruction is to skip the missed dose entirely. It is generally advised not to take a double dose to compensate for the one that was missed.


Q: Is Seroxine XR known to cause any weight changes?

A: Official documents indicate that changes in weight have been reported as adverse events in clinical trials for both adults and children. These changes included reports of both weight loss and weight gain. Regulatory documents state that monitoring for changes in weight is advised during treatment.


Q: What are the most common reasons a doctor would prescribe Seroxine XR?

A: The medicine is approved by regulatory bodies to treat several specific mental health conditions. These official indications typically include Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Panic Disorder.


Q: How does the extended-release (XR) mechanism actually work in the body?

A: The extended-release capsule is a specialized delivery system that is not affected by stomach acidity (pH-independent). The medication is held within tiny pellets, and the medicine is released from these pellets into the body through a process called diffusion. This process is controlled by the pellets' protective coating, which allows the drug to be released slowly and consistently.


Q: Can Seroxine XR cause anxiety or nervousness when first starting it?

A: According to the official product information, nervousness is listed as a common adverse reaction observed in clinical trials. Some patients have also reported experiencing increased anxiety when first starting the treatment. Regulatory information notes that these adverse effects are often reported more commonly when treatment is initiated.


Q: Is there a maximum time someone can be on Seroxine XR?

A: Regulatory documents recognize that the conditions the medicine treats are often long-term or lifelong. Because of this, the expected duration for patients who respond to treatment is often at least six months to a year, and may extend for many years. The official length of use is determined based on the necessary clinical assessment for the condition being treated.


Q: Are there any specific foods or drinks to avoid with Seroxine XR?

A: Official instructions state that the medicine should always be taken with food. Official guidance indicates that concomitant use of alcohol is advised against while taking this medication. Beyond this, regulatory documents do not list specific foods or non-alcoholic beverages that must be strictly avoided due to documented interaction risks.


Q: Is Seroxine XR considered a 'controlled' substance?

A: No, the active ingredient in Seroxine XR, known as Venlafaxine, is not classified as a controlled substance. This classification is based on the definitions provided by regulatory bodies like the U.S. Controlled Substances Act.


Q: Is the tiredness mentioned in the side effects usually temporary?

A: The official safety information does not specify the exact duration of side effects like somnolence, which is the medical term for drowsiness. However, regulatory documents do indicate that adverse reactions are generally more common during the first phase of treatment or when the dosage is being adjusted.


Q: What is the difference in how Seroxine XR works compared to other similar medications?

A: The mechanism of Seroxine XR is defined as a dual action because its active ingredients potently block the reuptake of both Serotonin and Norepinephrine. This pharmacological profile classifies it as an SNRI (Serotonin-Norepinephrine Reuptake Inhibitor). This dual action is the main factor that distinguishes its mechanism from a class like the SSRIs, which primarily focus only on Serotonin.


Q: Can Seroxine XR impact the results of laboratory blood tests?

A: Regulatory guidance notes that monitoring blood pressure and lipid levels periodically is required during treatment. Additionally, caution is advised when taking the medication with certain blood thinners, as this combination may affect coagulation (blood clotting) indices.


Q: What is meant by the 'Boxed Warning' on Seroxine XR literature?

A: The Boxed Warning is the most stringent safety notification issued by the FDA. For this medication, the warning draws attention to the increased risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24) when they take antidepressant medications.


Q: Does Seroxine XR affect a person's ability to drive or operate machinery?

A: The official medication guide indicates that Seroxine XR may cause drowsiness and can potentially affect a person's judgment, thinking, or movements. Official guidance notes that driving or operating machinery should be avoided until an individual knows how the medicine affects them.


Q: Why is Seroxine XR available in several different strengths?

A: The medicine is manufactured in various strengths to support the necessary process of dose adjustment. This allows healthcare providers to start the treatment at a lower dose and then increase it gradually, which is typically done to find the most appropriate and tolerated dose for each individual patient.


Q: Does Seroxine XR have the potential to interact with herbal products?

A: Official guidance identifies St. John's wort as an herbal remedy that is advised against for concomitant use. This combination may increase the risk of side effects, including a potentially serious condition known as Serotonin Syndrome.


Q: How does the extended-release formula change the risk of side effects?

A: The extended-release (XR) formulation is engineered to maintain more stable concentrations of the medicine in the blood compared to the immediate-release version. This consistent concentration level is intended to improve tolerability. In turn, this mechanism may contribute to a reduced incidence of certain short-term side effects.


Q: Why are people often told not to share Seroxine XR with others?

A: Seroxine XR is a prescription-only medicine that requires individualized dosing and careful supervision. Official guidance describes the medicine as a treatment that requires careful screening due to specific risks and contraindications, such as concurrent use with MAOIs.


Q: Are there any specific lifestyle changes recommended when starting Seroxine XR?

A: Regulatory guidance notes that the use of alcoholic beverages is advised against, and activities like driving or operating heavy machinery should be avoided until the medicine's effects are known. These points emphasize caution regarding activities that require alertness and coordination.


Q: Why is Seroxine XR sometimes prescribed for different conditions?

A: The medicine is approved by regulatory bodies for use in treating several distinct conditions. Its uses, or indications, are officially listed as Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Panic Disorder.


Q: Is Seroxine XR used for pain relief?

A: The primary official indications for Seroxine XR are focused on mood and anxiety disorders. However, due to its dual mechanism of action, the medicine has been explored in studies for conditions that involve pain. This includes its use in the prevention of migraine headaches and for managing certain types of nerve-related (neuropathic) pain.


Q: Is Seroxine XR a drug that causes dependence or withdrawal symptoms?

A: Regulatory documents recognize the potential for a discontinuation syndrome, which is a set of symptoms that can occur upon stopping the medicine. To minimize the likelihood and severity of this reaction, official instructions mandate a process of gradual dose reduction (tapering) when treatment is being concluded.


Q: Does Seroxine XR have a generic version available?

A: Yes, generic versions of this medicine are available. Regulatory agencies like the FDA have approved generic extended-release capsules containing the active ingredient, Venlafaxine Hydrochloride.


Q: Can men and women experience different side effects from Seroxine XR?

A: The overall side effect profile is similar for all adults, but official information specifically documents that some adverse effects can manifest differently based on sex. For example, the FDA label lists sexual dysfunction as a potential side effect, noting different forms in males (like erectile dysfunction) and females (like delayed orgasm).


Q: What should be discussed with a doctor before starting Seroxine XR?

A: Regulatory guidance identifies several key health factors that should be reviewed with a healthcare provider before initiating treatment. Key discussion points often include all prescription, over-the-counter, and herbal supplements, and any history of conditions like bipolar disorder, seizures, uncontrolled blood pressure, or angle-closure glaucoma.

Advertisements

How should Seroxine XR be stored and disposed of?

Storage and Handling Requirements

Seroxine XR (Venlafaxine Extended-Release Capsules) must be stored at Controlled Room Temperature (CRT), defined as 20^circmathrmC to 25^circmathrmC (68^circmathrmF to 77^circmathrmF). To preserve stability, the medication must be kept from freezing and protected from excessive heat, moisture, and direct light in a closed container.

Child-Safety and Disposal

As a regulatory mandate, the medicine must be kept out of the reach of children.

Disposal of unused or expired Seroxine XR should follow official guidelines. The preferred method is to use a local drug take-back program or mail-back system. It is generally instructed not to flush the medication down a toilet or pour it down a sink. If take-back is unavailable, disposal may be done by mixing the medicine with an unappealing substance, sealing it in a container, and placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seroxine XR found in:

A-Z Index: